ABOUT USNCE PROJECTSNDDS PROJECTSTIMELINESINVESTORSPRESSCONTACT US


   

Fluticasone + Salmeterol DPI

SPARC’s user- friendly DPI device is an inhalation–activated, premetered 60 dose device.

Our device delivers the drug at 50% of the dose of the branded product, and still offers the same efficacy. At half the dose, our product has demonstrated comparable efficacy to Advair Diskus® in a 100 patient, Phase III clinical trial in India.

 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                        Technology
   
Home
About Us
NCE Projects
NDDS Projects
Timelines
Investors
Press
Contact Us
Careers
Site Map